Global Propofol Injectable Emulsion Market Growth 2026-2032

September 2026 | 137 pages | ID: GCEE78646785EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Propofol Injectable Emulsion market size is predicted to grow from US$ 1394 million in 2025 to US$ 1796 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.

In 2024, global propofol injectable emulsion production reached approximately 376 million units, with an average global market price of around US$ 3.7 per unit. Propofol is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting. Propofol injectable emulsion is a sterile, nonpyrogenic emulsion containing propofol suitable for intravenous administration. Its gross profit margin generally ranges from 50% to 80%.

Increasing Demand:

The demand for propofol is increasing, driven by the rising incidence of chronic diseases, surgeries, and medical procedures. The aging population, changing lifestyles, and growing healthcare infrastructure in emerging markets are also contributing to the increasing demand for propofol.

Technological Advancements:

Advances in drug delivery systems and monitoring technologies are enhancing the use of propofol. Innovations such as target-controlled infusion (TCI) systems allow for more precise administration, improving safety and efficacy.

Expanding Applications:

Beyond traditional surgical and diagnostic procedures, propofol’s applications are expanding into areas such as pediatric anesthesia, veterinary medicine, and even in treating certain psychiatric disorders like refractory depression through off-label use.

Intensified Competition:

Competition among manufacturers will intensify further in the coming years. In addition, propofol substitutes will try to occupy more market share.

LP Information, Inc. (LPI) ' newest research report, the “Propofol Injectable Emulsion Industry Forecast” looks at past sales and reviews total world Propofol Injectable Emulsion sales in 2025, providing a comprehensive analysis by region and market sector of projected Propofol Injectable Emulsion sales for 2026 through 2032. With Propofol Injectable Emulsion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol Injectable Emulsion industry.

This Insight Report provides a comprehensive analysis of the global Propofol Injectable Emulsion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol Injectable Emulsion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Propofol Injectable Emulsion market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol Injectable Emulsion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol Injectable Emulsion.

This report presents a comprehensive overview, market shares, and growth opportunities of Propofol Injectable Emulsion market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 1%
  • 2%
  • Other
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Fresenius Kabi
  • Pfizer
  • B. Braun
  • Sagent Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Rusoma
  • Centurion Healthcare
  • Wellona Pharma
  • Hikma Pharmaceuticals
  • Avet Pharmaceuticals
  • Xi’an Libang Pharmaceutical
  • Guangdong Jiabo Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Jiangsu Yingke Biopharmaceutical
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Propofol Injectable Emulsion market?
  • What factors are driving Propofol Injectable Emulsion market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Propofol Injectable Emulsion market opportunities vary by end market size?
  • How does Propofol Injectable Emulsion break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Propofol Injectable Emulsion Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Propofol Injectable Emulsion by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Propofol Injectable Emulsion by Country/Region, 2021, 2025 & 2032
  2.2 Propofol Injectable Emulsion Segment by Type
  2.2.1 1%
  2.2.2 2%
  2.2.3 Other
  2.2.4 Propofol Injectable Emulsion Sales by Type
  2.2.4.1 Global Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
  2.2.4.2 Global Propofol Injectable Emulsion Revenue and Market Share by Type (2021-2026)
  2.2.4.3 Global Propofol Injectable Emulsion Sale Price by Type (2021-2026)
  2.3 Propofol Injectable Emulsion Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Propofol Injectable Emulsion Sales by Application
  2.3.4.1 Global Propofol Injectable Emulsion Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Propofol Injectable Emulsion Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Propofol Injectable Emulsion Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Propofol Injectable Emulsion Breakdown Data by Company
  3.1.1 Global Propofol Injectable Emulsion Annual Sales by Company (2021-2026)
  3.1.2 Global Propofol Injectable Emulsion Sales Market Share by Company (2021-2026)
  3.2 Global Propofol Injectable Emulsion Annual Revenue by Company (2021-2026)
  3.2.1 Global Propofol Injectable Emulsion Revenue by Company (2021-2026)
  3.2.2 Global Propofol Injectable Emulsion Revenue Market Share by Company (2021-2026)
  3.3 Global Propofol Injectable Emulsion Sale Price by Company
  3.4 Key Manufacturers Propofol Injectable Emulsion Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Propofol Injectable Emulsion Product Location Distribution
  3.4.2 Players Propofol Injectable Emulsion Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PROPOFOL INJECTABLE EMULSION BY GEOGRAPHIC REGION

  4.1 World Historic Propofol Injectable Emulsion Market Size by Geographic Region (2021-2026)
  4.1.1 Global Propofol Injectable Emulsion Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Propofol Injectable Emulsion Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Propofol Injectable Emulsion Market Size by Country/Region (2021-2026)
  4.2.1 Global Propofol Injectable Emulsion Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Propofol Injectable Emulsion Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Propofol Injectable Emulsion Sales Growth
  4.4 APAC Propofol Injectable Emulsion Sales Growth
  4.5 Europe Propofol Injectable Emulsion Sales Growth
  4.6 Middle East & Africa Propofol Injectable Emulsion Sales Growth

5 AMERICAS

  5.1 Americas Propofol Injectable Emulsion Sales by Country
  5.1.1 Americas Propofol Injectable Emulsion Sales by Country (2021-2026)
  5.1.2 Americas Propofol Injectable Emulsion Revenue by Country (2021-2026)
  5.2 Americas Propofol Injectable Emulsion Sales by Type (2021-2026)
  5.3 Americas Propofol Injectable Emulsion Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Propofol Injectable Emulsion Sales by Region
  6.1.1 APAC Propofol Injectable Emulsion Sales by Region (2021-2026)
  6.1.2 APAC Propofol Injectable Emulsion Revenue by Region (2021-2026)
  6.2 APAC Propofol Injectable Emulsion Sales by Type (2021-2026)
  6.3 APAC Propofol Injectable Emulsion Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Propofol Injectable Emulsion by Country
  7.1.1 Europe Propofol Injectable Emulsion Sales by Country (2021-2026)
  7.1.2 Europe Propofol Injectable Emulsion Revenue by Country (2021-2026)
  7.2 Europe Propofol Injectable Emulsion Sales by Type (2021-2026)
  7.3 Europe Propofol Injectable Emulsion Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Propofol Injectable Emulsion by Country
  8.1.1 Middle East & Africa Propofol Injectable Emulsion Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Propofol Injectable Emulsion Revenue by Country (2021-2026)
  8.2 Middle East & Africa Propofol Injectable Emulsion Sales by Type (2021-2026)
  8.3 Middle East & Africa Propofol Injectable Emulsion Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Propofol Injectable Emulsion
  10.3 Manufacturing Process Analysis of Propofol Injectable Emulsion
  10.4 Industry Chain Structure of Propofol Injectable Emulsion

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Propofol Injectable Emulsion Distributors
  11.3 Propofol Injectable Emulsion Customer

12 WORLD FORECAST REVIEW FOR PROPOFOL INJECTABLE EMULSION BY GEOGRAPHIC REGION

  12.1 Global Propofol Injectable Emulsion Market Size Forecast by Region
  12.1.1 Global Propofol Injectable Emulsion Forecast by Region (2027-2032)
  12.1.2 Global Propofol Injectable Emulsion Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Propofol Injectable Emulsion Forecast by Type (2027-2032)
  12.7 Global Propofol Injectable Emulsion Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Fresenius Kabi
  13.1.1 Fresenius Kabi Company Information
  13.1.2 Fresenius Kabi Propofol Injectable Emulsion Product Portfolios and Specifications
  13.1.3 Fresenius Kabi Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Fresenius Kabi Main Business Overview
  13.1.5 Fresenius Kabi Latest Developments
  13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Propofol Injectable Emulsion Product Portfolios and Specifications
  13.2.3 Pfizer Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
  13.3 B. Braun
  13.3.1 B. Braun Company Information
  13.3.2 B. Braun Propofol Injectable Emulsion Product Portfolios and Specifications
  13.3.3 B. Braun Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 B. Braun Main Business Overview
  13.3.5 B. Braun Latest Developments
  13.4 Sagent Pharmaceuticals
  13.4.1 Sagent Pharmaceuticals Company Information
  13.4.2 Sagent Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
  13.4.3 Sagent Pharmaceuticals Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Sagent Pharmaceuticals Main Business Overview
  13.4.5 Sagent Pharmaceuticals Latest Developments
  13.5 Dr. Reddy's Laboratories
  13.5.1 Dr. Reddy's Laboratories Company Information
  13.5.2 Dr. Reddy's Laboratories Propofol Injectable Emulsion Product Portfolios and Specifications
  13.5.3 Dr. Reddy's Laboratories Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Dr. Reddy's Laboratories Main Business Overview
  13.5.5 Dr. Reddy's Laboratories Latest Developments
  13.6 Rusoma
  13.6.1 Rusoma Company Information
  13.6.2 Rusoma Propofol Injectable Emulsion Product Portfolios and Specifications
  13.6.3 Rusoma Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Rusoma Main Business Overview
  13.6.5 Rusoma Latest Developments
  13.7 Centurion Healthcare
  13.7.1 Centurion Healthcare Company Information
  13.7.2 Centurion Healthcare Propofol Injectable Emulsion Product Portfolios and Specifications
  13.7.3 Centurion Healthcare Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Centurion Healthcare Main Business Overview
  13.7.5 Centurion Healthcare Latest Developments
  13.8 Wellona Pharma
  13.8.1 Wellona Pharma Company Information
  13.8.2 Wellona Pharma Propofol Injectable Emulsion Product Portfolios and Specifications
  13.8.3 Wellona Pharma Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Wellona Pharma Main Business Overview
  13.8.5 Wellona Pharma Latest Developments
  13.9 Hikma Pharmaceuticals
  13.9.1 Hikma Pharmaceuticals Company Information
  13.9.2 Hikma Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
  13.9.3 Hikma Pharmaceuticals Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Hikma Pharmaceuticals Main Business Overview
  13.9.5 Hikma Pharmaceuticals Latest Developments
  13.10 Avet Pharmaceuticals
  13.10.1 Avet Pharmaceuticals Company Information
  13.10.2 Avet Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
  13.10.3 Avet Pharmaceuticals Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Avet Pharmaceuticals Main Business Overview
  13.10.5 Avet Pharmaceuticals Latest Developments
  13.11 Xi’an Libang Pharmaceutical
  13.11.1 Xi’an Libang Pharmaceutical Company Information
  13.11.2 Xi’an Libang Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.11.3 Xi’an Libang Pharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Xi’an Libang Pharmaceutical Main Business Overview
  13.11.5 Xi’an Libang Pharmaceutical Latest Developments
  13.12 Guangdong Jiabo Pharmaceutical
  13.12.1 Guangdong Jiabo Pharmaceutical Company Information
  13.12.2 Guangdong Jiabo Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.12.3 Guangdong Jiabo Pharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Guangdong Jiabo Pharmaceutical Main Business Overview
  13.12.5 Guangdong Jiabo Pharmaceutical Latest Developments
  13.13 Sichuan Biokin Pharmaceutical
  13.13.1 Sichuan Biokin Pharmaceutical Company Information
  13.13.2 Sichuan Biokin Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.13.3 Sichuan Biokin Pharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Sichuan Biokin Pharmaceutical Main Business Overview
  13.13.5 Sichuan Biokin Pharmaceutical Latest Developments
  13.14 Sichuan Kelun Pharmaceutical
  13.14.1 Sichuan Kelun Pharmaceutical Company Information
  13.14.2 Sichuan Kelun Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.14.3 Sichuan Kelun Pharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Sichuan Kelun Pharmaceutical Main Business Overview
  13.14.5 Sichuan Kelun Pharmaceutical Latest Developments
  13.15 Jiangsu Nhwa Pharmaceutical
  13.15.1 Jiangsu Nhwa Pharmaceutical Company Information
  13.15.2 Jiangsu Nhwa Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.15.3 Jiangsu Nhwa Pharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
  13.15.5 Jiangsu Nhwa Pharmaceutical Latest Developments
  13.16 Jiangsu Yingke Biopharmaceutical
  13.16.1 Jiangsu Yingke Biopharmaceutical Company Information
  13.16.2 Jiangsu Yingke Biopharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
  13.16.3 Jiangsu Yingke Biopharmaceutical Propofol Injectable Emulsion Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Jiangsu Yingke Biopharmaceutical Main Business Overview
  13.16.5 Jiangsu Yingke Biopharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Propofol Injectable Emulsion Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Propofol Injectable Emulsion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1%
Table 4. Major Players of 2%
Table 5. Major Players of Other
Table 6. Global Propofol Injectable Emulsion Sales by Type (2021-2026) & (Million Units)
Table 7. Global Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
Table 8. Global Propofol Injectable Emulsion Revenue by Type (2021-2026) & ($ million)
Table 9. Global Propofol Injectable Emulsion Revenue Market Share by Type (2021-2026)
Table 10. Global Propofol Injectable Emulsion Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Propofol Injectable Emulsion Sale by Application (2021-2026) & (Million Units)
Table 12. Global Propofol Injectable Emulsion Sale Market Share by Application (2021-2026)
Table 13. Global Propofol Injectable Emulsion Revenue by Application (2021-2026) & ($ million)
Table 14. Global Propofol Injectable Emulsion Revenue Market Share by Application (2021-2026)
Table 15. Global Propofol Injectable Emulsion Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Propofol Injectable Emulsion Sales by Company (2021-2026) & (Million Units)
Table 17. Global Propofol Injectable Emulsion Sales Market Share by Company (2021-2026)
Table 18. Global Propofol Injectable Emulsion Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Propofol Injectable Emulsion Revenue Market Share by Company (2021-2026)
Table 20. Global Propofol Injectable Emulsion Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Propofol Injectable Emulsion Producing Area Distribution and Sales Area
Table 22. Players Propofol Injectable Emulsion Products Offered
Table 23. Propofol Injectable Emulsion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Propofol Injectable Emulsion Sales by Geographic Region (2021-2026) & (Million Units)
Table 27. Global Propofol Injectable Emulsion Sales Market Share Geographic Region (2021-2026)
Table 28. Global Propofol Injectable Emulsion Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Propofol Injectable Emulsion Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Propofol Injectable Emulsion Sales by Country/Region (2021-2026) & (Million Units)
Table 31. Global Propofol Injectable Emulsion Sales Market Share by Country/Region (2021-2026)
Table 32. Global Propofol Injectable Emulsion Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Propofol Injectable Emulsion Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Propofol Injectable Emulsion Sales by Country (2021-2026) & (Million Units)
Table 35. Americas Propofol Injectable Emulsion Sales Market Share by Country (2021-2026)
Table 36. Americas Propofol Injectable Emulsion Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Propofol Injectable Emulsion Sales by Type (2021-2026) & (Million Units)
Table 38. Americas Propofol Injectable Emulsion Sales by Application (2021-2026) & (Million Units)
Table 39. APAC Propofol Injectable Emulsion Sales by Region (2021-2026) & (Million Units)
Table 40. APAC Propofol Injectable Emulsion Sales Market Share by Region (2021-2026)
Table 41. APAC Propofol Injectable Emulsion Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Propofol Injectable Emulsion Sales by Type (2021-2026) & (Million Units)
Table 43. APAC Propofol Injectable Emulsion Sales by Application (2021-2026) & (Million Units)
Table 44. Europe Propofol Injectable Emulsion Sales by Country (2021-2026) & (Million Units)
Table 45. Europe Propofol Injectable Emulsion Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Propofol Injectable Emulsion Sales by Type (2021-2026) & (Million Units)
Table 47. Europe Propofol Injectable Emulsion Sales by Application (2021-2026) & (Million Units)
Table 48. Middle East & Africa Propofol Injectable Emulsion Sales by Country (2021-2026) & (Million Units)
Table 49. Middle East & Africa Propofol Injectable Emulsion Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Propofol Injectable Emulsion Sales by Type (2021-2026) & (Million Units)
Table 51. Middle East & Africa Propofol Injectable Emulsion Sales by Application (2021-2026) & (Million Units)
Table 52. Key Market Drivers & Growth Opportunities of Propofol Injectable Emulsion
Table 53. Key Market Challenges & Risks of Propofol Injectable Emulsion
Table 54. Key Industry Trends of Propofol Injectable Emulsion
Table 55. Propofol Injectable Emulsion Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Propofol Injectable Emulsion Distributors List
Table 58. Propofol Injectable Emulsion Customer List
Table 59. Global Propofol Injectable Emulsion Sales Forecast by Region (2027-2032) & (Million Units)
Table 60. Global Propofol Injectable Emulsion Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Propofol Injectable Emulsion Sales Forecast by Country (2027-2032) & (Million Units)
Table 62. Americas Propofol Injectable Emulsion Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Propofol Injectable Emulsion Sales Forecast by Region (2027-2032) & (Million Units)
Table 64. APAC Propofol Injectable Emulsion Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Propofol Injectable Emulsion Sales Forecast by Country (2027-2032) & (Million Units)
Table 66. Europe Propofol Injectable Emulsion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Propofol Injectable Emulsion Sales Forecast by Country (2027-2032) & (Million Units)
Table 68. Middle East & Africa Propofol Injectable Emulsion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Propofol Injectable Emulsion Sales Forecast by Type (2027-2032) & (Million Units)
Table 70. Global Propofol Injectable Emulsion Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Propofol Injectable Emulsion Sales Forecast by Application (2027-2032) & (Million Units)
Table 72. Global Propofol Injectable Emulsion Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Fresenius Kabi Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 74. Fresenius Kabi Propofol Injectable Emulsion Product Portfolios and Specifications
Table 75. Fresenius Kabi Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Fresenius Kabi Main Business
Table 77. Fresenius Kabi Latest Developments
Table 78. Pfizer Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Propofol Injectable Emulsion Product Portfolios and Specifications
Table 80. Pfizer Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. B. Braun Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 84. B. Braun Propofol Injectable Emulsion Product Portfolios and Specifications
Table 85. B. Braun Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. B. Braun Main Business
Table 87. B. Braun Latest Developments
Table 88. Sagent Pharmaceuticals Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 89. Sagent Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
Table 90. Sagent Pharmaceuticals Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sagent Pharmaceuticals Main Business
Table 92. Sagent Pharmaceuticals Latest Developments
Table 93. Dr. Reddy's Laboratories Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy's Laboratories Propofol Injectable Emulsion Product Portfolios and Specifications
Table 95. Dr. Reddy's Laboratories Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Dr. Reddy's Laboratories Main Business
Table 97. Dr. Reddy's Laboratories Latest Developments
Table 98. Rusoma Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 99. Rusoma Propofol Injectable Emulsion Product Portfolios and Specifications
Table 100. Rusoma Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Rusoma Main Business
Table 102. Rusoma Latest Developments
Table 103. Centurion Healthcare Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 104. Centurion Healthcare Propofol Injectable Emulsion Product Portfolios and Specifications
Table 105. Centurion Healthcare Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Centurion Healthcare Main Business
Table 107. Centurion Healthcare Latest Developments
Table 108. Wellona Pharma Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 109. Wellona Pharma Propofol Injectable Emulsion Product Portfolios and Specifications
Table 110. Wellona Pharma Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Wellona Pharma Main Business
Table 112. Wellona Pharma Latest Developments
Table 113. Hikma Pharmaceuticals Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 114. Hikma Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
Table 115. Hikma Pharmaceuticals Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Hikma Pharmaceuticals Main Business
Table 117. Hikma Pharmaceuticals Latest Developments
Table 118. Avet Pharmaceuticals Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 119. Avet Pharmaceuticals Propofol Injectable Emulsion Product Portfolios and Specifications
Table 120. Avet Pharmaceuticals Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Avet Pharmaceuticals Main Business
Table 122. Avet Pharmaceuticals Latest Developments
Table 123. Xi’an Libang Pharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 124. Xi’an Libang Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 125. Xi’an Libang Pharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Xi’an Libang Pharmaceutical Main Business
Table 127. Xi’an Libang Pharmaceutical Latest Developments
Table 128. Guangdong Jiabo Pharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 129. Guangdong Jiabo Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 130. Guangdong Jiabo Pharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Guangdong Jiabo Pharmaceutical Main Business
Table 132. Guangdong Jiabo Pharmaceutical Latest Developments
Table 133. Sichuan Biokin Pharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 134. Sichuan Biokin Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 135. Sichuan Biokin Pharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Sichuan Biokin Pharmaceutical Main Business
Table 137. Sichuan Biokin Pharmaceutical Latest Developments
Table 138. Sichuan Kelun Pharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 139. Sichuan Kelun Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 140. Sichuan Kelun Pharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Sichuan Kelun Pharmaceutical Main Business
Table 142. Sichuan Kelun Pharmaceutical Latest Developments
Table 143. Jiangsu Nhwa Pharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 144. Jiangsu Nhwa Pharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 145. Jiangsu Nhwa Pharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Jiangsu Nhwa Pharmaceutical Main Business
Table 147. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 148. Jiangsu Yingke Biopharmaceutical Basic Information, Propofol Injectable Emulsion Manufacturing Base, Sales Area and Its Competitors
Table 149. Jiangsu Yingke Biopharmaceutical Propofol Injectable Emulsion Product Portfolios and Specifications
Table 150. Jiangsu Yingke Biopharmaceutical Propofol Injectable Emulsion Sales (Million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Jiangsu Yingke Biopharmaceutical Main Business
Table 152. Jiangsu Yingke Biopharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Propofol Injectable Emulsion
Figure 2. Propofol Injectable Emulsion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Propofol Injectable Emulsion Sales Growth Rate 2021-2032 (Million Units)
Figure 7. Global Propofol Injectable Emulsion Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Propofol Injectable Emulsion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Propofol Injectable Emulsion Sales Market Share by Country/Region (2025)
Figure 10. Propofol Injectable Emulsion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1%
Figure 12. Product Picture of 2%
Figure 13. Product Picture of Other
Figure 14. Global Propofol Injectable Emulsion Sales Market Share by Type in 2026
Figure 15. Global Propofol Injectable Emulsion Revenue Market Share by Type (2021-2026)
Figure 16. Propofol Injectable Emulsion Consumed in Hospital
Figure 17. Global Propofol Injectable Emulsion Market: Hospital (2021-2026) & (Million Units)
Figure 18. Propofol Injectable Emulsion Consumed in Clinic
Figure 19. Global Propofol Injectable Emulsion Market: Clinic (2021-2026) & (Million Units)
Figure 20. Propofol Injectable Emulsion Consumed in Other
Figure 21. Global Propofol Injectable Emulsion Market: Other (2021-2026) & (Million Units)
Figure 22. Global Propofol Injectable Emulsion Sale Market Share by Application (2025)
Figure 23. Global Propofol Injectable Emulsion Revenue Market Share by Application in 2026
Figure 24. Propofol Injectable Emulsion Sales by Company in 2026 (Million Units)
Figure 25. Global Propofol Injectable Emulsion Sales Market Share by Company in 2026
Figure 26. Propofol Injectable Emulsion Revenue by Company in 2026 ($ millions)
Figure 27. Global Propofol Injectable Emulsion Revenue Market Share by Company in 2026
Figure 28. Global Propofol Injectable Emulsion Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Propofol Injectable Emulsion Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Propofol Injectable Emulsion Sales 2021-2026 (Million Units)
Figure 31. Americas Propofol Injectable Emulsion Revenue 2021-2026 ($ millions)
Figure 32. APAC Propofol Injectable Emulsion Sales 2021-2026 (Million Units)
Figure 33. APAC Propofol Injectable Emulsion Revenue 2021-2026 ($ millions)
Figure 34. Europe Propofol Injectable Emulsion Sales 2021-2026 (Million Units)
Figure 35. Europe Propofol Injectable Emulsion Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Propofol Injectable Emulsion Sales 2021-2026 (Million Units)
Figure 37. Middle East & Africa Propofol Injectable Emulsion Revenue 2021-2026 ($ millions)
Figure 38. Americas Propofol Injectable Emulsion Sales Market Share by Country in 2026
Figure 39. Americas Propofol Injectable Emulsion Revenue Market Share by Country (2021-2026)
Figure 40. Americas Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
Figure 41. Americas Propofol Injectable Emulsion Sales Market Share by Application (2021-2026)
Figure 42. United States Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Propofol Injectable Emulsion Sales Market Share by Region in 2026
Figure 47. APAC Propofol Injectable Emulsion Revenue Market Share by Region (2021-2026)
Figure 48. APAC Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
Figure 49. APAC Propofol Injectable Emulsion Sales Market Share by Application (2021-2026)
Figure 50. China Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 54. India Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Propofol Injectable Emulsion Sales Market Share by Country in 2026
Figure 58. Europe Propofol Injectable Emulsion Revenue Market Share by Country (2021-2026)
Figure 59. Europe Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
Figure 60. Europe Propofol Injectable Emulsion Sales Market Share by Application (2021-2026)
Figure 61. Germany Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 62. France Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Propofol Injectable Emulsion Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Propofol Injectable Emulsion Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Propofol Injectable Emulsion Sales Market Share by Application (2021-2026)
Figure 69. Egypt Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Propofol Injectable Emulsion Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Propofol Injectable Emulsion in 2026
Figure 75. Manufacturing Process Analysis of Propofol Injectable Emulsion
Figure 76. Industry Chain Structure of Propofol Injectable Emulsion
Figure 77. Channels of Distribution
Figure 78. Global Propofol Injectable Emulsion Sales Market Forecast by Region (2027-2032)
Figure 79. Global Propofol Injectable Emulsion Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Propofol Injectable Emulsion Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Propofol Injectable Emulsion Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Propofol Injectable Emulsion Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Propofol Injectable Emulsion Revenue Market Share Forecast by Application (2027-2032)


More Publications